Announcements & Press Releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Sep 16, 2020
Accelerate Diagnostics, Inc. (NASDAQ:AXDX) today announced that the Company has received U.S. Food and Drug Administration (FDA) clearance for a new suite of product enhancements to the Accelerate...
-
Sep 10, 2020
Accelerate Diagnostics, Inc. (NASDAQ:AXDX) and BioCheck, Inc., a privately-held San Francisco-based company focused on in vitro diagnostics, today announced that the U.S. Food and Drug...
-
Aug 24, 2020
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) today announced that Nedal Safwat has been appointed Chief Strategy Officer. Dr. Safwat joins Accelerate from BioMerieux, the world's leading...
-
Aug 18, 2020
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) and BioCheck, Inc., a privately-held San Francisco-based company focused on in vitro diagnostics, today announced that the U.S. Food and Drug...
-
Aug 6, 2020
Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the second quarter ended June 30, 2020. "While the progress of new contracts and go-lives continued to be slowed...
-
Jul 16, 2020
Accelerate Diagnostics, Inc. announced today that management will host a conference call on Thursday, August 6, 2020 at 4:30 p.m. Eastern Time to review 2020 second quarter financial results. To...
-
May 7, 2020
Accelerate Diagnostics, Inc. (NASDAQ: AXDX), today announced financial results for the quarter ending March 31, 2020 and provided a business update regarding the impact of the ongoing COVID-19...
-
Apr 15, 2020
Accelerate Diagnostics, Inc. (NASDAQ: AXDX), today announced preliminary financial results for the quarter ending March 31, 2020 and provided a business update regarding the impact of the ongoing...
-
Apr 15, 2020
Accelerate Diagnostics, Inc. (NASDAQ:AXDX) and BioCheck, Inc., a privately-held San Francisco-based company focused on in vitro diagnostics, today announced that they have entered into a...
-
Feb 27, 2020
Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the fourth quarter and full year ended December 31, 2019. "Our contracted instrument trajectory continued over the...
-
Feb 18, 2020
Accelerate Diagnostics, Inc. announced today that management will host a conference call on Thursday, February 27, 2020 at 4:30 p.m. Eastern Time to review 2019 fourth quarter and full-year...
-
Jan 13, 2020
Accelerate Diagnostics, Inc. (NASDAQ: AXDX), today announced preliminary financial results for the quarter and year ending December 31, 2019. Highlights for the fourth quarter and full-year 2019...
-
Jan 3, 2020
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that the company is scheduled to present at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco on January 15, 2020, at...
-
Dec 4, 2019
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that Larry Mehren, chief executive officer, will participate in a 25-minute question and answer session at the 31st Annual Piper Jaffray...
-
Dec 4, 2019
Accelerate Diagnostics, Inc. (NASDAQ:AXDX) today announced that Lawrence Mehren will retire from the company. Jack Phillips, the company's Chief Operating Officer, has been unanimously appointed...
-
Dec 2, 2019
Accelerate Diagnostics, Inc. (NASDAQ:AXDX) announced today that Louise Francesconi has been appointed to the company's Board of Directors. Ms. Francesconi has served as a director on the board of...
-
Nov 7, 2019
Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the third quarter ended September 30, 2019. "Our placement and revenue results for the third quarter came in below...
-
Nov 4, 2019
Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced that Roland Diggelmann has been appointed to its Board of Directors. "On behalf of the entire board, I am delighted to welcome Roland to...
-
Oct 17, 2019
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that it will report financial results for the third quarter of 2019 after the market close on Thursday, November 7, 2019. The company's...
-
Oct 3, 2019From IDWeek™, the annual meeting of the Infectious Diseases Society of America (IDSA) held in Washington, DC October 2 - 6.
Accelerate Diagnostics, Inc. today announced presentation of full data from three outcome studies at IDWeek™ 2019. The full data being presented build upon the high-level findings that were...
-
Sep 18, 2019
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) today announced the release of positive results from three clinical studies on the Accelerate Pheno™ system that will be presented at IDWeek™ 2019....
-
Aug 8, 2019
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) today announced that Jack Phillips has been appointed Chief Operating Officer. Mr. Phillips joins Accelerate from Roche Diagnostics, the world's leading...
-
Aug 8, 2019
Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the second quarter ended June 30, 2019. "We achieved mixed results in the second quarter, as revenue and...
-
Aug 2, 2019
Accelerate Diagnostics, Inc. announced the release and CE marking of its latest Accelerate PhenoTest™ BC kit, declaring conformity to the European Directive 98/79/EC on in vitro diagnostic...
-
Jul 8, 2019
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that it will report financial results for the second quarter of 2019 after the market close on Thursday, August 8, 2019. The company's...
-
May 24, 2019
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) today announced that Chief Executive Officer, Larry Mehren, and Chief Financial Officer, Steve Reichling will present at the 39th Annual William Blair...
-
May 9, 2019
Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the first quarter ended March 31, 2019. "We are pleased with our continued momentum in the first quarter, as we...
-
Apr 26, 2019
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) today announced that it will report financial results for the first quarter of 2019 after the market close on Thursday, May 9, 2019. The Company's...
-
Mar 8, 2019
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that the company is scheduled to present at the Cowen and Company 39th Annual Health Care Conference in Boston on Wednesday, March 13,...
-
Feb 19, 2019
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) today announced financial results for the fourth quarter and fiscal year ended December 31, 2018. "I am pleased to report an improvement in our...
-
Feb 5, 2019
Accelerate Diagnostics, Inc. announced today that management will host a conference call on Tuesday, February 19, 2019 at 4:30 p.m. Eastern Time to review 2018 fourth quarter and full-year...
-
Jan 6, 2019Added 117 commercially contracted U.S. instruments in Q4, doubling the regional installed base
Accelerate Diagnostics, Inc. (NASDAQ: AXDX), today announced preliminary financial results for the quarter ending December 31, 2018. The company reported a 127.2% increase in U.S. instruments...
-
Jan 2, 2019
Accelerate Diagnostics announced today that the company is scheduled to present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 9, 2019, at 2:30 PM...
-
Nov 27, 2018
Accelerate Diagnostics, Inc. has joined with Sepsis Alliance to celebrate #GivingTuesday, November 27th, a global day of giving that harnesses the collective power of individuals, communities and...
-
Nov 6, 2018Revenue Placements up 40 Percent in U.S., Total Revenue up 64 Percent
Accelerate Diagnostics, Inc. today announced financial results for the quarter ending September 30, 2018. The company reported a 40% increase in U.S. instruments placed under commercial contract,...
-
Oct 17, 2018
Accelerate Diagnostics, Inc. announced today that it will host a conference call on Tuesday, November 6, 2018 to review the company's third quarter 2018 financial results and commercial progress....
-
Sep 27, 2018
Accelerate Diagnostics, Inc. announced today that Joan Martin resigned from his position as Executive Vice President and Head of Europe, Middle East, and Africa and will be leaving the company for...
-
Aug 7, 2018
Accelerate Diagnostics, Inc. announced today that it received an Innovative Technology contract from Vizient, Inc., the largest member-driven health care performance improvement company in the...
-
Aug 6, 2018
Accelerate Diagnostics, Inc. today announced financial results for the quarter ending June 30, 2018. The company posted revenue of $1.7 million, up 142% from the prior year quarter, and reported a...
-
Jul 19, 2018
TUCSON, Ariz., July 19, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today it will host a conference call on Monday, August 6, 2018 to review the company’s second quarter 2018...
-
Jun 5, 2018
TUCSON, Ariz., June 05, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today that Lawrence Mehren, President and Chief Executive Officer is scheduled to speak at the William Blair...
-
May 9, 2018
TUCSON, Ariz., May 09, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. today announced financial results for the quarter ending March 31, 2018. The company generated revenue of $801,000, up...
-
Apr 30, 2018
TUCSON, Ariz., April 30, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today it will host a conference call on Wednesday, May 9, 2018 to review its first quarter 2018 financial...
-
Apr 21, 2018Four integrated symposium sessions, 11 poster presentations, and case studies will cover the clinical value of integrating diagnostic stewardship into current sepsis protocols given the rising rates of antibiotic resistance
TUCSON, Ariz., April 21, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. today announced the sizeable release of new data presented by the company, its customers, and clinical experts during the
-
Mar 23, 2018
TUCSON, Ariz., March 23, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (“Accelerate Diagnostics”) (NASDAQ:AXDX) today announced the pricing of $150.0 million aggregate principal amount...
-
Mar 22, 2018
TUCSON, Ariz., March 22, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (NASDAQ:AXDX) today announced its intention to offer, subject to market conditions and other factors, $150.0 million...
-
Feb 15, 2018
TUCSON, Ariz., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. today announced preliminary full-year 2017 financial results including the quarter ending December 31, 2017. The...
-
Feb 8, 2018
TUCSON, Ariz., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. will host a conference call on Thursday, February 15, 2018 to review its fourth quarter and full-year financial...
-
Jan 10, 2018
TUCSON, Ariz., Jan. 10, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today its declaration of conformity to the European In Vitro Diagnostic Directive 98/79/EC and CE mark of...
-
Jan 4, 2018
TUCSON, Ariz., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today that Lawrence Mehren, President and Chief Executive Officer is scheduled to speak at the 36th Annual...